Not all chemotherapy is the same

Chemotherapy remains an important part of Cancer treatment, but it is not required for every Cancer. The drug or combination I recommend depends on the type and stage of Cancer, its biology, the purpose of treatment, previous therapy, organ function and the individual receiving it. Just as the drugs are different, their side effects and intensity are different too. My approach is to explain why a particular regimen is being used, what benefit we expect, which side effects are relevant to that regimen, and what we can do in advance to reduce those risks.

What is chemotherapy?

Chemotherapy uses medicines that interfere with the growth and division of Cancer cells. Different drugs work in different ways — some damage DNA, some interfere with DNA replication, and others interrupt cell division. Combinations may be used because the medicines can attack Cancer through complementary mechanisms.

Chemotherapy may be given before surgery (neoadjuvant), after surgery (adjuvant), with radiotherapy, or for advanced Cancer to control disease, relieve symptoms and prolong survival. In some Cancers it is combined with immunotherapy or targeted therapy; in others, chemotherapy may not be needed at all.

Common chemotherapy regimens, in brief

These are familiar examples, not a complete treatment list. The same Cancer can have several appropriate options depending on stage, biomarkers, age, organ function and treatment goals.

A patient receiving weekly paclitaxel, FOLFOX, cisplatin with radiotherapy or dose-dense AC may have very different side effects and supportive-care needs. “Chemotherapy” should not be treated as a single uniform experience. I prefer to discuss the side effects of the actual regimen being planned rather than give every patient one long generic list: hair loss is common with anthracyclines and many taxanes but not with every drug; neuropathy is particularly relevant with taxanes and oxaliplatin; diarrhoea may be more prominent with irinotecan; kidney function, electrolytes and hearing are important with cisplatin; and hand-foot syndrome is more relevant with capecitabine. Bone-marrow suppression can occur with many regimens, but the degree varies. Blood counts and organ function are monitored as appropriate, and if toxicity develops, treatment may be delayed, doses modified, or supportive medicines added according to the treatment goal and clinical situation.

Will I need to be admitted to hospital?

Usually, no. Most commonly used chemotherapy regimens are delivered in a day-care or outpatient setting, and many patients go home the same day. However, an unplanned hospital visit or admission can occasionally be required. There is no single accurate hospitalisation percentage for chemotherapy as a whole — admission risk varies with the regimen and dose, the Cancer being treated, age and fitness, organ function, nutritional status, other medical conditions and the supportive care being used.

Common reasons for urgent assessment or admission include fever with neutropenia or infection, dehydration from persistent vomiting or diarrhoea, severe weakness or electrolyte disturbance, and significant anaemia or bleeding related to low blood counts. Less commonly, organ-specific complications such as kidney injury, thrombosis or a severe infusion reaction can need urgent care.

Managing chemotherapy side effects: modern supportive care

Supportive care is planned alongside chemotherapy from the beginning. The aim is to prevent side effects where possible, treat them early, and help you stay well enough to continue treatment safely.

My approach to chemotherapy looks at the Cancer, the evidence and the person in front of me: age, fitness, organ function, other medical conditions, work and family responsibilities, nutrition, priorities and what matters most during treatment. If chemotherapy is recommended, you should understand why it is being recommended, which medicines are being used, which side effects are most relevant to that specific regimen, what can be prevented or reduced in advance, when to contact the oncology team urgently, and what modifications or alternatives are reasonable if significant toxicity develops. Every treatment decision deserves a reason. If chemotherapy is the right treatment, the goal is to deliver it as effectively and safely as possible while preserving function, dignity and quality of life.

This page is for general patient education and should not be used to predict an individual patient’s toxicity or hospitalisation risk. Regimen-specific counselling is based on the actual drugs, doses, treatment intent and patient factors. Medically reviewed by Dr Sneha Kommineni.